Results 211 to 220 of about 86,629 (276)

The Role of Therapeutic Plasma Exchange in the Management of Myeloma-Related Cast Nephropathy: A 10-Year Real-World Cohort Study. [PDF]

J Clin Med
Salur H, Atas U, Alhan N, Vural E, Iltar U, Yucel OK, Salim O.   +6 more
europepmc   +1 more source

Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets [PDF]

, 2018
et al,, Li, Shunqiang, Shao, Jieya
core   +1 more source

Targeting lipogenesis promotes the synergistic effect of the selective HDAC6 inhibitor ITF3756 with bortezomib in colon cancer cells. [PDF]

Front Pharmacol
Franzò M, Zichittella C, Di Liberto D, Pratelli G, Affranchi F, Notaro A, Giuliano M, Emanuele S.   +7 more
europepmc   +1 more source

Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

, 2014
Antonio Palumbo, Sara Bringhen, Alessandra Larocca, Davide Rossi, Francesco Di Raimondo, Valeria Magarotto, Francesca Patriarca, Anna Levi, Giulia Benevolo, Iolanda Donatella Vincelli, Mariella Grasso, Luca Franceschini, Daniela Gottardi, Renato Zambello, Vittorio Montefusco, Antonietta Falcone, Paola Omedè, Roberto Marasca, Fortunato Morabito, Roberto Mina, Tommasina Guglielmelli, Chiara Nozzoli, Roberto Passera, Gianluca Gaïdano, Massimo Offidani, Roberto Ria, Maria Teresa Petrucci, Pellegrino Musto, Mario Boccadoro, Michèle Cavo   +29 more
openalex   +2 more sources

Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Oncol
Hu B, Wang J, Fang D, Jiang L, Li T, Cao J.   +5 more
europepmc   +1 more source

Oral selinexor–dexamethasone for triple-class refractory multiple myeloma [PDF]

, 2019
al., et, Vij, Ravi
core   +1 more source

Comparative Investigation of Cytotoxic Effects of Structurally Diverse Small Molecules and In Silico Analysis of 1-Acetyl-4-(4-Hydroxyphenyl)piperazine. [PDF]

J Cell Mol Med
Yerlikaya A, Tümer E, Güzel M.
europepmc   +1 more source

Rare and varied presentations of plasmablastic lymphoma: A case series. [PDF]

SAGE Open Med Case Rep
Al-Mashdali AF, Jibril F, Rizvi SM, Taha R, Bakr M, Elkourashy SA.   +5 more
europepmc   +1 more source

Emerging Real-World Treatment Patterns and Clinical Outcomes of Multiple Myeloma in Argentina and Brazil: Insights from the TOTEMM Study in the Private Healthcare Sector. [PDF]

Curr Oncol
Hungria V, Maiolino A, Pessoa de Magalhães RJ, Pitombeira de Lacerda M, Remaggi G, Scibona P, Seehaus C, Brulc E, Savoy N, Fantl D, Soares C, Abreu G, Queiroz J, Bernardino G, Tanaka S, Carrizo M, Simonovich VA, Bertoldo Teixeira Fernandes T, Aggarwal B.   +18 more
europepmc   +1 more source

Construction and validation of a simple, scoreable model for predicting infection risk in patients with multiple myeloma: a retrospective single-center study. [PDF]

Front Oncol
Tu SK, Yang J, Min SD, Fan HJ, Hu M, Tian J, Li M, Song K.   +7 more
europepmc   +1 more source